By proceeding, you agree to our Terms of Use and Privacy Policy.
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy.
11-14 October 2022
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional advi
Event Ended
Scotland
Paid
Edinburgh
16-20 May 2023
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting, which we've expanded to four full days in 2023, is the best place for people in the field to learn fr
Hybrid
Los Angeles
12-13 July 2023
Join us at the Focus on Eye Health Summit 2023, a groundbreaking event that brings together diverse voices from around the world to explore the profound impact of sight on our lives. From the earliest stages of our journey to our final days, our visi
Virtual
27-27 July 2023
Welcome to OIS Retina 2023, the leading gathering of clinical, corporate, and capital leaders dedicated to advancing novel technologies and addressing the most significant unmet medical needs in the field of retina. This highly anticipated event brin
USA
Seattle
18-20 August 2023
This two-and-a-half-day symposium is intended to provide ophthalmologists with an update on the diagnosis and management of vitreoretinal diseases. Emphasis will be placed on conditions that have seen recent new developments. Didactic lectures and vi
Chicago